MOTS-c dosage for muscle repair in Canada typically ranges from 5 mg to 10 mg administered subcutaneously two to three times per week, based on emerging research. This mitochondrial-derived peptide is gaining attention for its dual role in enhancing cellular energy production and accelerating muscle recovery. In Canada, researchers are exploring MOTS-c as a promising peptide for muscle recovery, with studies highlighting its unique mechanism of action on mitochondrial function.
What is MOTS-c and How Does It Work?
MOTS-c is a 16-amino-acid peptide encoded within the mitochondrial genome. It translocates to the nucleus under metabolic stress to regulate gene expression. By activating the AMPK pathway, MOTS-c enhances glucose uptake and fatty acid oxidation, directly boosting mitochondrial efficiency. This process supports muscle repair by increasing ATP availability and reducing oxidative damage.
Unlike growth hormone secretagogues, MOTS-c operates through a distinct mitochondrial-nuclear crosstalk. This makes it a unique candidate for muscle recovery research, especially in models of metabolic dysfunction or age-related decline. Early studies suggest it may also improve insulin sensitivity and physical endurance.
MOTS-c Dosage for Muscle Repair: Research Protocols
Current research protocols for MOTS-c dosage in muscle repair vary, but common regimens include 5 mg injected subcutaneously every other day or 10 mg three times per week. Cycle lengths range from 4 to 8 weeks. These dosages are derived from preclinical studies and anecdotal reports, as human trials are still limited.
For mitochondrial benefits, lower doses of 2.5 mg to 5 mg daily have been explored. Researchers in Canada often start with 5 mg twice weekly and adjust based on observed effects. It is critical to reconstitute MOTS-c with bacteriostatic water and store it properly to maintain stability.
Reconstitution and Administration
To reconstitute a 10 mg vial of MOTS-c, add 1 mL of bacteriostatic water. This yields a concentration of 10 mg/mL. For a 5 mg dose, draw 0.5 mL. Use an insulin syringe for subcutaneous injection into the abdomen or thigh. Rotate injection sites to prevent irritation.
Proper handling is essential, as peptides can degrade if not refrigerated after reconstitution. Always follow sterile procedures. For more on peptide reconstitution, see our guide on BPC 157 reconstitution and dosage protocols.
Mitochondrial Benefits of MOTS-c
The mitochondrial benefits of MOTS-c extend beyond muscle repair. By improving mitochondrial respiration, it may combat age-related decline in cellular energy. Research shows MOTS-c increases NAD+ levels and reduces reactive oxygen species, protecting cells from damage. These effects are particularly relevant for skeletal muscle, which relies heavily on mitochondrial function.
In animal models, MOTS-c improved exercise capacity and reduced muscle wasting. It also promoted myoblast differentiation, a key step in muscle regeneration. These findings position MOTS-c as a potential peptide for muscle recovery research in Canada, where interest in mitochondrial health is growing.
Comparing MOTS-c to Other Muscle Repair Peptides
While BPC-157 and TB-500 are well-known for healing tendons and ligaments, MOTS-c targets the metabolic underpinnings of muscle repair. Its mitochondrial mechanism offers a complementary approach. For a direct comparison of two popular healing peptides, read our article on BPC 157 vs TB 500 for muscle repair.
MOTS-c may be stacked with other peptides, but research on combinations is scarce. Always consult available literature before combining compounds.
MOTS-c Research in Canada
In Canada, MOTS-c is sold for research purposes only and is not approved for human use. Researchers can source MOTS-c from specialized peptide suppliers that ship domestically. When buying MOTS-c in Canada, verify the vendor provides third-party purity testing and ships discreetly.
Prices for a 10 mg vial of MOTS-c in Canada typically range from $60 to $120 CAD, depending on the supplier and purity. Some vendors offer discounts for bulk orders. Always check for recent reviews and lab reports to ensure quality.
Legal Status and Sourcing
MOTS-c is not regulated under the Controlled Drugs and Substances Act but falls under the Food and Drugs Act as a research chemical. It cannot be sold for human consumption. Researchers must comply with institutional guidelines when purchasing and using MOTS-c.
For those exploring other peptides available in Canada, our guide on buying BPC-157 5mg in Canada provides insights into reliable sourcing practices.
Potential Side Effects and Safety
Reported side effects of MOTS-c are minimal in research settings. Some users note mild injection site reactions or transient fatigue. Because MOTS-c influences metabolism, it could theoretically cause hypoglycemia if dosed improperly. Monitor blood glucose levels during experiments.
Long-term safety data are lacking. Researchers should adhere to established protocols and avoid excessive dosing. As with any peptide, individual responses may vary.
MOTS-c Cycle Length and Expected Results
A typical MOTS-c cycle for muscle repair lasts 6 to 8 weeks. Some protocols include a loading phase of daily dosing for the first week, followed by maintenance doses. Results may include improved recovery time, reduced muscle soreness, and enhanced endurance.
Mitochondrial benefits may take longer to manifest, often requiring consistent use over several cycles. Researchers should document changes in biomarkers like lactate threshold or ATP levels to assess efficacy.
Stacking MOTS-c with Other Peptides
Although not extensively studied, MOTS-c is sometimes combined with BPC-157 for comprehensive healing. BPC-157 promotes angiogenesis and tissue repair, while MOTS-c enhances cellular energy. For a deeper dive into BPC-157's effects, see our review of BPC-157 studies, results, and documented side effects.
Always research potential interactions before stacking peptides. Start with low doses of each compound to assess tolerance.
Key Takeaways for Researchers
MOTS-c offers a novel mechanism for supporting muscle repair and mitochondrial health. Its dosage in Canadian research contexts typically ranges from 5 mg to 10 mg two to three times weekly. While promising, human data remain limited, and all use should adhere to research guidelines.
For those investigating peptides for muscle recovery, MOTS-c represents an exciting frontier. Ensure proper sourcing, storage, and ethical compliance to maximize the value of your research.
References to off-label or research-only use describe what has been reported in the scientific literature, not what is recommended.